高尿酸与肥胖的交互作用对非酒精性脂肪肝病患病率的影响

doi:10.3969/j.issn.1000-8535.2024.08.004

摘要/Abstract

摘要： 目的研究高尿酸（UA）和肥胖的交互作用对非酒精性脂肪肝病（NAFLD）患病率的影响。方法采用病例对照的研究法,选取2021年1月至2021年12月兰州市某医院健康体检中心进行常规健康体检的504人为研究对象,按照诊断标准分为NAFLD组187人和非NAFLD 组317人。采用Logistic 回归模型、相乘、相加交互模型探讨非酒精性脂肪肝病患病风险的影响因素及因素间的交互作用。结果多因素条件Logistic回归分析可知,肥胖（OR=4.87,95%CI：3.01~7.89）,糖尿病患者（OR=3.40,95%CI：1.51~7.68）,幽门螺杆菌（Hp）携带者（OR=1.62,95%CI：1.03~2.57）,高尿酸血症的NAFLD患病风险增加,分别是正常者、非糖尿病患者、非Hp携带者,非高尿酸血症的4.87倍,3.40倍,1.62倍,2.28倍,在调整混杂因素后交互作用结果显示,高尿酸血症和肥胖对NAFLD患病率有相乘交互作用（OR=0.30,95%CI：0.10~0.88,P=0.029）、但无相加交互作用（相对超额危险度比=3.15、归因比=0.24、协同指数=1.34）。结论 BMI、糖尿病、Hp是NAFLD患病的独立危险因素,其中高尿酸血症和超重与肥胖对NAFLD患病有相乘交互作用,无相加交互作用。

关键词: 高尿酸血症, 肥胖, 交互作用, 病例对照研究

Abstract: Objective To explore the influence of the interaction of high uric acid（UA）and obesity on the prevalence of non-alcoholic fatty liver disease（NAFLD）．Methods Using a case-control study method,504 people who underwent routine health checkups at the health checkup centre of a hospital in Lanzhou City from January 2021 to December 2021 were enrolled in the study,and 187 people were included in the NAFLD group and 317 people in the non-NAFLD group according to the diagnostic criteria．Logistic regression models,multiplicative and additive interaction models were used to investigate the factors affecting the risk factors of NAFLD and the interaction between the factors．Results Multifactorial conditional logistic regression analysis showed that the risk of NAFLD was increased in obese（OR=4.87,95% CI：3.01-7.89）,diabetic patients（OR=3.40,95% CI：1.51-7.68）,Helicobacter pylori（Hp）carriers（OR=1.62,95% CI：1.03-2.57）;the increased risk of NAFLD prevalence in hyperuricaemia patients was 4.87,3.40,1.62,and 2.28 times higher than that of normal,non-diabetic,non-Hp carriers,and non-hyperuricemic individuals,respectively．And the adjusted interaction showed a multiplicative interaction of hyperuricaemia and obesity on the prevalence of NAFLD after controlling for the confounders（OR=0.30,95% CI：0.10-0.88,P=0.029）,but no additive interaction （relative excess risk due to interaction=3.15,attributable proportion due to interaction=0.24,and synergy index=1.34） interactions．Conclusions BMI,diabetes mellitus,and Hp were independent risk factors for the prevalence of NAFLD,with hyperuricaemia and overweight and obesity having multiplicative interaction and no additive interaction．

Key words: hyperuricemia, obesity, interaction, case control study

李三三, 周钰博, 吕珍, 王引弟, 吴建军. 高尿酸与肥胖的交互作用对非酒精性脂肪肝病患病率的影响[J]. 广州医药, 2024, 55(8): 843-851.

LI Sansan, ZHOU Yubo, LV Zhen, WANG Yindi, WU Jianjun. The effect of the interaction between hyperuric acid and obesity on the prevalence of non-alcoholic fatty liver disease[J]. Guangzhou Medical Journal, 2024, 55(8): 843-851.

参考文献

[1] STAUFER K,HUBER-SCHÖNAUER U,STREBINGER G,et al.Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease[J].J Hepatol,2022,77(4):918-930.
[2] LÓPEZ-GONZÁLEZ Á A,ALTISENCH JANÉ B,MASMIQUEL COMAS L,et al.Impact of COVID-19 lockdown on non-alcoholic fatty liver disease and insulin resistance in adults:A before and after pandemic lockdown longitudinal study[J].Nutrients,2022,14(14):2795-2731.
[3] AKAHANE T,AKAHANE M,NAMISAKI T,et al.Association between non-alcoholic fatty liver disease and chronic kidney disease:A cross-sectional study[J].Journal of Clinical Medicine,2020,9(6):1635-1640.
[4] KUMAR R,DIXIT V K,SHUKLA S K,et al.The association of Helicobacter pylori infection in non-alcoholic fatty liver disease patients[J].Indian J Gastroenterol,2017,36(1):A33.
[5] 郭立新. 从《高尿酸血症和痛风治疗中国专家共识》谈高尿酸血症的治疗[J].药品评价,2014,11(1):23-31.
[6] 诸骏仁,高润霖,赵水平,等.中国成人血脂异常防治指南(2016年修订版)[J].中国循环杂志,2016,31(10):937-953.
[7] 《中国高血压防治指南》修订委员会.中国高血压防治指南(2018年修订版)[J].心脑血管病防治,2019,19(1):1-44.
[8] 汪泓,刘兆云.Hp感染对胃溃疡患者胃泌素、白细胞介素1β的影响及其临床意义[J].武警后勤学院学报(医学版),2021,30(7):63-65.
[9] 董玉玮,李文,王陶,等.亚甲基四氢叶酸还原酶基因多态性与长期接触有机磷农药相互作用对2型糖尿病的影响[J].卫生研究,2019,48(4):621-627.
[10] 赵小兰,聂婵,汪莉菲,等.高尿酸与体重指数交互作用对苗族人群代谢综合征的影响[J].现代预防医学,2023,50(4):592-603.
[11] 万保玉,苏禹,高茜茜,等.生活满意度和轮班及其交互作用对石化企业员工蓄积性疲劳的影响[J].环境与职业医学,2023,40(9):1039-1045.
[12] 吴挺丰,廖献花,钟碧慧.中国部分地区非酒精性脂肪肝病的流行情况[J].临床肝胆病杂志,2020,36(6):1370-1373.
[13] 陈宏,董文琴,崔丽芝,等.军队飞行人员高尿酸血症及非酒精性脂肪性肝病的调查分析[J].空军医学杂志,2021,37(1):30-33.
[14] 武智慧,高艳,徐锦江.锦州地区体检人群高尿酸血症与非酒精性脂肪肝的相关性分析[J].锦州医科大学学报,2021,42(1):73-76.
[15] 曾佳,白雪,尹相林,等.尿酸与DNA损伤之间关系的研究进展[J].生命科学,2023,35(10):1372-1379.
[16] 张阳,杨森,许丽娜.长链非编码RNA在非酒精性脂肪肝病中的研究进展[J].中国药理学通报,2023,39(7):1213-1217.
[17] CUNHA G M,GUZMAN G,CORREA de MELLO L L,et al.Efficacy of a 2-Month Very Low-Calorie Ketogenic Diet(VLCKD)Compared to a Standard Low-Calorie Diet in Reducing Visceral and Liver Fat Accumulation in Patients With Obesity[J].Frontiers in Endocrinology,2020(11):607.
[18] THOMSEN M N,SKYTTE M J,SAMKANI A,et al.Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes:a randomised controlled trial[J].Diabetologia,2022,65(3):506-517.
[19] ARORA C,MALHOTRA A,RANJAN P,et al.Effect of intensive weight-loss intervention on metabolic,ultrasound and anthropometric parameters among patients with obesity and non-alcoholic fatty liver disease:an RCT[J].European Journal of Clinical Nutrition,2022,76(9):1332-1338.
[20] FUCHS A,SAMOVSKI D,SMITH G I,et al.Associations among adipose tissue immunology,inflammation and exosomes and insulin sensitivity in people with obesity and nonalcoholic fatty liver disease[J].Gastroenterology,2021,161(3):968-981.e12.
[21] GOVAERE O,PETERSEN S K,MARTINEZ-LOPEZ N,et al.Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease[J].J Hepatology,2022,76(5):1001-1012.
[22] HAGSTRÖM H,SIMON T G,ROELSTRAETE B,et al.Maternal obesity increases the risk and severity of NAFLD in offspring[J].Journal of Hepatology,2021,75(5):1042-1048.
[23] 刘芳,李言,徐琳,等.高血压和腹型肥胖与糖尿病患病的交互作用[J].上海预防医学,2023,35(9):885-888.
[24] 张至贤,黄雪雪,胡婕,等.中学生心理健康素养和非自杀性自伤行为交互作用与自杀相关行为关联[J].中国公共卫生,2022,38(12):1517-1522.
[25] 袁悦,李楠,任爱国,等.流行病学研究中相加和相乘尺度交互作用的分析[J].现代预防医学,2015,42(6):961-975.
[26] ZHOU M,YANG N,XING X,et al.Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease[J].BMC gastroenterology,2021,21(1):43-50.